Frequency and diagnostic findings of type I and type IV reactions to beta‐lactam antibiotics – significance of the time interval between clinical reaction and skin testing
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024
DOI: 10.1111/ddg.15506 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Kimberley Farmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Allergology and Immunology, Department of Dermatology, Venereology, and Allergology, Charité - Universitätsmedizin Berlin. Hauptthemen laut MEDLINE: Skin Tests, beta-Lactams, Anti-Bacterial Agents, Drug Hypersensitivity. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The prevalence of allergies to beta‐lactam antibiotics is significantly overestimated based on anamnestic data ‐ with significant medical and economic consequences. The aim of the study was to determine the frequency of immediate and delayed type reactions to beta‐lactam antibiotics in order to optimize diagnostics and therapy. One focus was on the time interval between reaction and testing. Patients and methodology Anamnestic and diagnostic data of patients with suspected allergy to beta‐lactam antibiotics who were examined in our department between 2020 and 2022 were analyzed.
Results
27/116 (23%) patients reacted in the skin tests. Type I sensitizations were detected in 4/35 patients (11%), type IV sensitizations in 23/83 (28%). In the case of negative in vitro diagnostics and skin testing, inpatient provocation tests were performed in 41/89 (46%). Type I allergies were confirmed in two of the 13 provoked patients (15%) with immediate type reactions, type IV allergies in three of 29 (10%) with delayed type reactions. The results were clearly related to the time interval after reaction. At less than one year, 19% (22/116) reacted, whereas only 4% (5/116) reacted at more than one year (for type I reaction 9% vs. 3%; for type IV reaction 23% vs. 5%).
Conclusions
The importance of the time interval between clinical event and allergological testing supports the guideline recommendation for skin testing within one year. Guideline recommendations on the diagnostic procedure for unclear reactions that occurred in the more distant past are desirable in order to rule out allergies to beta‐lactam antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergology and Immunology, Department of Dermatology, Venereology, and Allergology, Charité - Universitätsmedizin Berlin.
ORCID-Profile: Margitta Worm
Zitieren
APA
Farmer, K., Oestmann, E., & Worm, M. (2024). Frequency and diagnostic findings of type I and type IV reactions to beta‐lactam antibiotics – significance of the time interval between clinical reaction and skin testing. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15506
Vancouver
Farmer K, Oestmann E, Worm M. Frequency and diagnostic findings of type I and type IV reactions to beta‐lactam antibiotics – significance of the time interval between clinical reaction and skin testing. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15506
BibTeX
@article{Farmer2024,
author = {Farmer, Kimberley and Oestmann, Elsbeth and Worm, Margitta},
title = {Frequency and diagnostic findings of type I and type IV reactions to beta‐lactam antibiotics – significance of the time interval between clinical reaction and skin testing},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
doi = {10.1111/ddg.15506}
}
EUVIMED